CT45-6 activators function through a variety of mechanisms, primarily influencing signaling pathways and cellular processes that facilitate the expression and activity of this cancer/testis antigen. Certain activators directly stimulate adenylyl cyclase, consequently raising intracellular cAMP levels, which promotes a conducive signaling milieu for the transcription of genes such as CT45-6. The elevated cAMP effectively leads to the phosphorylation of various transcription factors, thereby potentially enhancing the expression and activity of CT45-6. Other activators function by increasing intracellular calcium concentrations, thus triggering calcium-dependent signaling cascades that may elevate CT45-6 expression through transcriptional regulation. These calcium-related pathways are influenced by compounds that either serve as calcium ionophores or indirectly raise calcium levels, thereby indirectly supporting the transcriptional machinery necessary for CT45-6 expression.
Furthermore, the modulation of chromatin structure plays a significant role in CT45-6 activation, as compounds that inhibit histone deacetylases or DNA methyltransferases can alter chromatin accessibility. Such alterations potentially lead to an increase in CT45-6 expression by allowing transcription factors better access to DNA. Additionally, certain activators influence gene expression via interactions with nuclear receptors, further supporting the transcription of CT45-6. With the epigenetic landscape being crucial for gene expression, chemicals that affect histone acetylation or DNA methylation patterns can facilitate the manifestation of CT45-6 by enabling a more transcriptionally active chromatin state. In parallel, natural polyphenolic compounds are known to modulate various signaling pathways and transcription factors, which in turn may contribute to the upregulation of CT45-6, demonstrating the diverse biochemical mechanisms through which CT45-6 activators can exert their effects.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) which can lead to the phosphorylation of transcription factors that upregulate the expression of cancer/testis antigens such as CT45-6. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Increases intracellular calcium concentrations, which can activate calcium-dependent signaling cascades, potentially upregulating the expression of CT45-6 through transcriptional regulation mechanisms. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cAMP analogue that is resistant to degradation by phosphodiesterases, thus sustaining the activation of cAMP-dependent pathways which may lead to the increased activation of CT45-6 through enhanced gene expression. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore that raises intracellular calcium levels, potentially stimulating pathways that enhance the expression of CT45-6 by modulating transcription factor activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A beta-adrenergic agonist that increases cAMP levels via activation of adenylyl cyclase, potentially leading to the activation of CT45-6 by fostering an environment that supports its expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A metabolite of vitamin A that can regulate gene expression via retinoic acid receptors, potentially increasing the transcription and expression of CT45-6 in cells where it is epigenetically permissible. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Functions as a histone deacetylase inhibitor, promoting a more open chromatin state which may lead to the increased expression of CT45-6 by facilitating transcription factor access to DNA. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can lead to demethylation of gene promoter regions, potentially resulting in the increased expression of CT45-6 through relief of epigenetic silencing. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that can cause changes in chromatin structure, possibly leading to the enhanced expression of CT45-6 by enabling greater transcriptional activation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A polyphenol found in green tea that has been shown to influence gene expression, potentially inducing the expression of CT45-6 through modulation of epigenetic marks and transcription factor activity. | ||||||